TY - JOUR
T1 - Clinical stage I and II endometrial carcinoma
T2 - Multivariate analysis of prognostic factors
AU - Mammoliti, S.
AU - Bruzzone, M.
AU - Chiara, S.
AU - Vidali, A.
AU - Miglio, L.
AU - Fontana, V.
AU - Oliva, C.
AU - Compora, E.
AU - Giuntini, P.
AU - Centonze, M.
AU - Conte, P. F.
AU - Ragni, N.
PY - 1992
Y1 - 1992
N2 - In 221 patients with FIGO stage I and II endometrial carcinoma, the impact on survival of age at diagnosis, menopausal status, FIGO stage, myometrial invasion, tumor grade and histology was evaluated by univariate and multivariate analysis. At a median follow-up of 50 months (range 45-210), 42 patients had died, and therefore overall survival was 81% (179/221). Univariate analysis showed that age, menopausal status and histology did not influence survival, whereas FIGO stage, myometrial invasion and tumor grade were important prognostic factors. Multivariate analysis showed that tumor grade had a significant and independent impact on survival and confirmed that FIGO stage is the most important parameter influencing survival.
AB - In 221 patients with FIGO stage I and II endometrial carcinoma, the impact on survival of age at diagnosis, menopausal status, FIGO stage, myometrial invasion, tumor grade and histology was evaluated by univariate and multivariate analysis. At a median follow-up of 50 months (range 45-210), 42 patients had died, and therefore overall survival was 81% (179/221). Univariate analysis showed that age, menopausal status and histology did not influence survival, whereas FIGO stage, myometrial invasion and tumor grade were important prognostic factors. Multivariate analysis showed that tumor grade had a significant and independent impact on survival and confirmed that FIGO stage is the most important parameter influencing survival.
KW - Endometrial cancer
KW - Multuvariate analysis
KW - Prognostic-factors
UR - http://www.scopus.com/inward/record.url?scp=0026439347&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026439347&partnerID=8YFLogxK
M3 - Article
C2 - 1444199
AN - SCOPUS:0026439347
VL - 12
SP - 1415
EP - 1418
JO - Anticancer Research
JF - Anticancer Research
SN - 0250-7005
IS - 5
ER -